Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

ABPI Viewpoint: The Price Of Medicines, UK
According to the Department of Health, for every ÷£1 spent on healthcare in the UK, just 12p goes on medicines. Yet when it comes to debate around
generic viagra online
Yissum Signs A Collaboration Agreement With Aurum Ventures MKI For The Development Of Breakthrough Liver-Bypassing Oral Drug Delivery Nanotechnology
Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, announced today at the ILSI-Biomed Israel 2009 conference, it has signed an agreement with Aurum, Ventures MKI, the technology investment arm of Mr. Morris Kahn, for the development of a nanotechnology controlled release drug delivery platform that increases the bioavailability of orally administered lipophilic drugs. The technology was developed by Prof. Simon Benita at the Hebrew University"s School of Pharmacy.
News of the day
Individuals Who Apply Pesticides Are Found To Have Double The Risk Of Blood Disorder
A study involving 678 individuals who apply pesticides, culled from a U.S. Agricultural Health Study of over 50,000 farmers, recently found that exposure to certain pesticides doubles one"s risk of developing an abnormal blood condition called MGUS (monoclonal gammopathy of undetermined significance) compared with individuals in the general population. The disorder, characterized by an abnormal level of a plasma protein, requires lifelong monitoring as it is a pre-cancerous condition that can lead to multiple myeloma, a painful cancer of the plasma cells in the bone marrow. The study will appear in the June 18 issue of Blood, the official journal of the American Society of Hematology.
Oncology

Cognitive Behavioral Therapy Is An Effective Treatment For Chronic Insomnia

A majority of people experiencing chronic insomnia can experience a normalization of sleep parameters through the use of cognitive behavioral therapy for insomnia (CBT-I), according to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies. Results indicate that 50 percent to 60 percent of participants with chronic sleep onset insomnia, sleep maintenance insomnia or both experienced remission of their primary sleep difficulty. Among the 64 participants who completed five or more treatment sessions, there were significant improvements on presenting complaints, as well as all other measures, including sleep efficiency, average nightly awakenings, total sleep time and average nights of sleep medication use per week. According to lead author Ryan Wetzler, Psy.D, C.B.S.M. of Sleep Medicine Specialists in Louisville, Ky., results of the study indicate that multi-component CBT-I can be an effective approach for those experiencing chronic insomnia even when anxiety and depression are part of the clinical picture. "CBT-I teaches strategies to "reset" the bodily systems that regulate sleep," said Wetzler. "Since these systems also play a role in regulation of mood, pain and other bodily processes, skills developed through CBT-I may also have a positive impact on mood, anxiety, pain and other associated medical or psychiatric conditions." The study gathered data from 115 patients who had visited the Insomnia Treatment Program and Behavioral Sleep Medicine Clinic. Study participants included those with complaints of prolonged (more than 30 minutes) sleep onset latency (SOL), sleep maintenance insomnia (SMI), or both sleep onset and sleep maintenance insomnia (SOMI), and who had attended at least two treatment sessions. Participants were between the ages of 14 and 81 years, and 65 percent of the sample was female. The multi-component, CBT-I program included comprehensive evaluations of patients" habits, attitudes and knowledge concerning sleep. The program was designed to involve six to seven treatment sessions. Specific strategies included education on sleep regulating systems, sleep scheduling recommendations, sleep hygiene education, sleep consolidation therapy, stimulus control therapy, relaxation training, cognitive therapy and mindfulness training. According to Wetzler, a related study found that of participants who completed at least four treatment sessions of CBT-I, 78 percent of those using sleep medication for three or more nights per week were able to completely discontinue use of sleep medications. Findings from this study indicate that those who discontinued use of sleep medications not only stopped using drugs to sleep but also slept better than when they were taking sleep medications. Abstract Title: Effectiveness of a Cognitive-Behavioral Treatment Program for Chronic Insomnia Presentation Date: Tuesday, June 9 Category: Sleep Disorders - Insomnia Abstract ID: 0821 Kelly Wagner American Academy of Sleep Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009